Commonwealth Equity Services
SCPH

Commonwealth Equity Services’s scPharmaceuticals SCPH Stock Holding History

Commonwealth Equity Services’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,071
Closed -$172K – 4413
2025
Q2 		$172K Buy
45,071
+5,300
+13% +$16.5K ﹤0.01% 3955
2025
Q1 		$105K Buy
39,771
+1,000
+3% +$3.26K ﹤0.01% 3986
2024
Q4 		$137K Hold
38,771
– – ﹤0.01% 3853
2024
Q3 		$177K Buy
38,771
+2,000
+5% +$9.67K ﹤0.01% 3748
2024
Q2 		$160K Buy
36,771
+5,361
+17% +$23.6K ﹤0.01% 3705
2024
Q1 		$158K Hold
31,410
– – ﹤0.01% 3699
2023
Q4 		$197K Buy
31,410
+2,200
+8% +$12.6K ﹤0.01% 3514
2023
Q3 		$208K Hold
29,210
– – ﹤0.01% 3349
2023
Q2 		$298K Hold
29,210
– – ﹤0.01% 3063
2023
Q1 		$264K Hold
29,210
– – ﹤0.01% 3077
2022
Q4 		$209K Buy
29,210
+13,680
+88% +$83.6K ﹤0.01% 3194
2022
Q3 		$101K Hold
15,530
– – ﹤0.01% 3376
2022
Q2 		$74K Buy
+15,530
New +$76.9K ﹤0.01% 3424

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Commonwealth Equity Services's SCPH Position: Q3 2025 in Review

Commonwealth Equity Services sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 45,071 shares — an estimated $172K sold.

Commonwealth Equity Services first reported a position in SCPH in Q2 2022 and held it in 13 quarters. The position peaked at $298K in Q2 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

  • Commonwealth Equity Services reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 45,071 scPharmaceuticals shares in Q3 2025, an estimated $172K.
  • Commonwealth Equity Services first reported a position in scPharmaceuticals in Q2 2022 and held it in 13 quarters.
  • Commonwealth Equity Services's scPharmaceuticals position peaked at $298K in Q2 2023.
  • 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.